Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,426
Closed -$90.9K 181
2024
Q4
$90.9K Buy
3,426
+435
+15% +$11.8K 0.04% 74
2024
Q3
$86.6K Sell
2,991
-2,239
-43% -$65.3K 0.03% 85
2024
Q2
$146K Buy
+5,230
New +$144K 0.06% 71
2021
Q2
Sell
-8,443
Closed -$310K 102
2021
Q1
$310K Sell
8,443
-118
-1% -$4.19K 0.18% 59
2020
Q4
$315K Sell
8,561
-338
-4% -$12.4K 0.16% 65
2020
Q3
$310K Buy
8,899
+584
+7% +$20.5K 0.18% 59
2020
Q2
$258K Sell
8,315
-118
-1% -$4.01K 0.16% 65
2020
Q1
$256K Buy
8,433
+9
+0.1% +$307 0.19% 56
2019
Q4
$313K Buy
8,424
+164
+2% +$5.84K 0.18% 55
2019
Q3
$280K Buy
8,260
+266
+3% +$9.67K 0.17% 54
2019
Q2
$264K Buy
7,994
+63
+0.8% +$2.5K 0.17% 59
2019
Q1
$325K Buy
7,931
+62
+0.8% +$2.48K 0.21% 50
2018
Q4
$313K Sell
7,869
-306
-4% -$12.7K 0.22% 47
2018
Q3
$338K Buy
+8,175
New +$315K 0.25% 48
2018
Q1
$304K Buy
8,945
+2,542
+40% +$87.4K 0.27% 43
2017
Q4
$219K Buy
6,403
+52
+0.8% +$1.77K 0.17% 60
2017
Q3
$213K Buy
+6,351
New +$204K 0.17% 58

Other funds holding PFE

Denver PWM's PFE Position: Q1 2025 in Review

Denver PWM sold out of Pfizer (PFE) in Q1 2025, closing a stake of 3,426 shares — an estimated $90.9K sold.

Denver PWM first reported a position in PFE in Q3 2017 and held it in 17 quarters. The position peaked at $338K in Q3 2018. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Denver PWM reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Denver PWM sold 3,426 Pfizer shares in Q1 2025, an estimated $90.9K.
  • Denver PWM first reported a position in Pfizer in Q3 2017 and held it in 17 quarters.
  • Denver PWM's Pfizer position peaked at $338K in Q3 2018.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Denver PWM's 13F filing for Q1 2025, filed 7 May 2025.